成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 6893-02-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 6893-02-3
Chemical Structure| 6893-02-3
Structure of 6893-02-3 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 6893-02-3 ]

Related Doc. of [ 6893-02-3 ]

Alternatived Products of [ 6893-02-3 ]
Product Citations

Product Details of [ 6893-02-3 ]

CAS No. :6893-02-3 MDL No. :MFCD00002593
Formula : C15H12I3NO4 Boiling Point : -
Linear Structure Formula :- InChI Key :AUYYCJSJGJYCDS-LBPRGKRZSA-N
M.W : 650.97 Pubchem ID :5920
Synonyms :
Triiodothyronine;T3;NSC 80203;L-3,3’,5-Triiodothyronine;3,3’,5-Triiodo-L-thyronine;Liothyronine
Chemical Name :(S)-2-Amino-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)propanoic acid

Calculated chemistry of [ 6893-02-3 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 23
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.13
Num. rotatable bonds : 5
Num. H-bond acceptors : 5.0
Num. H-bond donors : 3.0
Molar Refractivity : 112.19
TPSA : 92.78 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -9.06 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.78
Log Po/w (XLOGP3) : 1.71
Log Po/w (WLOGP) : 3.95
Log Po/w (MLOGP) : 1.65
Log Po/w (SILICOS-IT) : 4.58
Consensus Log Po/w : 2.93

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.01
Solubility : 0.00637 mg/ml ; 0.00000979 mol/l
Class : Moderately soluble
Log S (Ali) : -3.27
Solubility : 0.346 mg/ml ; 0.000532 mol/l
Class : Soluble
Log S (SILICOS-IT) : -6.03
Solubility : 0.000615 mg/ml ; 0.000000944 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.98

Safety of [ 6893-02-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 6893-02-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 6893-02-3 ]

[ 6893-02-3 ] Synthesis Path-Downstream   1~18

  • 2
  • [ 605-65-2 ]
  • [ 6893-02-3 ]
  • (R)-2-(5-Dimethylamino-naphthalene-1-sulfonylamino)-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]-propionic acid [ No CAS ]
  • 3
  • [ 300-39-0 ]
  • 5-Iodo-1-oxa-spiro[2.5]octa-4,7-dien-6-one [ No CAS ]
  • [ 6893-02-3 ]
  • 6
  • 4-Hydroxymethyl-2-iodo-cyclohexa-2,5-dienone [ No CAS ]
  • [ 6893-02-3 ]
  • 7
  • [ 3392-07-2 ]
  • [ 6893-02-3 ]
  • Boc-Gly-T3 [ No CAS ]
YieldReaction ConditionsOperation in experiment
Production of the drug substance Gly-T3 ' HCl was performed as a one-pot reaction inside a 20-gallon glass lined reactor. To limit exposure of the workers to the potent material, the starting reagent T3 was prepared as a slurry in THF inside an EPO <DP n="44"/>isolator. The resulting slurry was then transferred to the 20-gallon reactor through a Teflon line. Subsequently, Boc-Gly-OSu was dissolved in THF, transferred to the 20-gallon reactor and then DIEA was dissolved in THF, and also transferred to the 20-gallon reactor. The suspension was stirred for 15 hours, at ambient temperature and became a clear solution. In process testing by HPLC (% AUC) of the collected sample after 15 hours showed a purity of 98.5 % for the desired compound, Boc- Gly-T3. The reaction was then quenched by adding water and the THF was removed by distillation. The solvent, TBME was then added and the batch was allowed to stir overnight at 5 to 10 0C. The solution was acidified by a 20 % aqueous Na2SO4ZNaHSO4 buffer solution. The product was extracted in TBME and the organic layers were combined in a 60 L Pope tank and dried with Na2SO4. The dried solution was then filtered through a 0.22 mum filter, charged into the 20- gallon reactor and stirred overnight at 15 0C. The TBME was removed by distillation, followed by IPAc chases (continuous feed), while the batch stirred overnight at 15 0C. The intermediate was Boc deprotected by pressurizing the 20- gallon reactor headspace with 30 psi HCl gas for 3 hours and 30 minutes. The obtained precipitate was filtered inside the isolator, washed with IPAc, and dried for 110 hours inside a vacuum oven at 35 0C. In process testing by GC showed the presence of 6.13 % residual IPAc. Therefore, the solids were hydrated (water displacement) for approximately 24 hours and dried until constant weight, in a vacuum oven for 50 hours at 35 0C. The material was packaged in glass amber bottles, which were put in polyethylene bags and stored at - 20 0C with desiccants.
  • 8
  • [ 1261501-03-4 ]
  • [ 6893-02-3 ]
  • [ 1261500-99-5 ]
  • [ 70-40-6 ]
  • 9
  • [ 903571-91-5 ]
  • [ 6893-02-3 ]
  • [ 64869-35-8 ]
  • [ 70-40-6 ]
  • 10
  • [ 25079-77-0 ]
  • [ 6893-02-3 ]
  • [ 70-40-6 ]
  • [ 209-22-3 ]
  • 12
  • [ 6893-02-3 ]
  • O-[3-iodo-4-(sulfooxy)phenyl]-3,5-diiodo-L-tyrosine sodium salt [ No CAS ]
YieldReaction ConditionsOperation in experiment
62% 3,5-diiodo-o-(4-hydroxy-3-iodophenyl)-L-tyrosine (100 g; 0.154 mol) was suspended in DMAC (2.0 L) under nitrogen atmosphere and stirred vigorously to avoid solid precipitation. After cooling to-5 C,While maintaining a temperature of -5 - 5 C, CSA (142.2 g; 1.229 mol) in 40 minutes at the end of the addition, the cooling was stopped and the reaction mixture was left under stirring for about 4 hours. The reaction mixture was added to a stirred aqueous solution of sodium carbonate (335.5 g; 4.5 liters in water) over a period of 1.5 hours, and precipitation of crystalline solids was observed as a mixture of inorganic salts from the resulting solution over time at the end of the addition, After filtering off the solids, the resulting solution was purified on an Amberlite XADTM 1600 by eluting with a water / acetone mixture with reduced polarity, and the eluate was collected in the flasks The product with the appropriate purity level The solvent was distilled off under reduced pressure to a concentration of 10 g / kg and the pH of the suspension was adjusted to 6.2 with HCl 1 N. The suspension was further diluted to a solids and residual water ratio of about 1: 3 The residue was treated with acetone for 2 hours under cooling and then filtered off and washed with acetone The product was dried at 40 C. under reduced pressure to give 74 g of T3S as a white solid, Yield of salt group: 62%.
  • 13
  • [ 6893-02-3 ]
  • O-[3-iodo-4-(sulfooxy)phenyl]-3,5-diiodo-N-sulfo-L-tyrosine disodium salt [ No CAS ]
  • 14
  • [ 6893-02-3 ]
  • [ 4732-82-5 ]
  • [ 10468-90-3 ]
  • [ 70-40-6 ]
  • [ 1596-67-4 ]
  • 16
  • [ 300-30-1 ]
  • [ 6893-02-3 ]
YieldReaction ConditionsOperation in experiment
The conversion of thyroxine to triiodothyronine in the lung:
  • 17
  • [ 6893-02-3 ]
  • 3,5-diiodo-N-[[(carboxymethyl)[2-[(carboxymethyl)[2-[bis(carboxymethyl)amino]ethyl]amino]ethyl]amino]acetyl]-O-[3-iodo-4-(sulfooxy)phenyl]-l-tyrosine [ No CAS ]
  • 18
  • [ 6893-02-3 ]
  • C36H47I3N4O14S2 [ No CAS ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Similar Product of
[ 6893-02-3 ]

Chemical Structure| 1213431-76-5

A1230085[ 1213431-76-5 ]

3,3',5-Triiodo-L-thyronine-13C6

Reason: Stable Isotope

; ;